This study found that the addition of ABT-888 reversed a significant portion of the changes in transcript levels induced by ethanol, suggesting that PARP inhibitors may be able to target the molecular mechanisms underlying the development of alcohol addiction. The gene discussed is PARP1; the disease is Addictive alcohol use.